22 filings · most recent first
TWST 8-K Filings
Twist Bioscience Reports 24 Revenue Growth In Q1 Fy25
Twist Bioscience Reports Fourth Quarter And Fiscal 2024 Financial Results
Twist Bioscience Reports Record Revenue And Improved Margins In Q3 Fy2024
Twist Bioscience Reports 25 Revenue Increase And Raises Guidance For Fy 2024
Twist Bioscience Reports Record Revenue And Raises Guidance For Fiscal 2024
Twist Bioscience Selected As Evaluator For Anthropics Aidriven Protein Design
Twist Bioscience Reports 23 Revenue Growth And Raises Fullyear Guidance
Twist Bioscience Reports Strong Q2 2026 Financial Results And Raises Guidance
Twist Bioscience Shareholders Approve Key Proposals
Twist Bioscience Announces 17 Revenue Growth And Raises Guidance
Twist Bioscience Reports 17 Revenue Growth For Q1 Fiscal 2026
Twist Bioscience Reports Record Revenues And Improved Financials For Fy 2025
Twist Bioscience Appoints Trynka Shineman Blake To Board Of Directors
Twist Bioscience Reports Record Revenue And Improved Margins For Q3 2025
Twist Bioscience Files Prospectus Supplement For Share Resale
Twist Bioscience Announces 300 Million Public Offering Of Common Stock
Twist Bioscience Corporation Announces Share Issuance In Stock Purchase
Twist Bioscience Spinout And Q2 2025 Financial Results
Shareholders Approve Key Amendments At Twist Bioscience Annual Meeting
James Thorburn Transitions To Consulting Role At Twist Bioscience
Twist Bioscience Shareholders Approve Director Elections And Neo Compensation
Twist Bioscience Appoints New Cfo Adam Laponis